Anti-infection
Industry academic brand

Sumitomo Pharma (Suzhou) Co., Ltd. has always been committed to the academic development of the anti-infection field, actively promoting knowledge exchanges and constantly advancing the development of the anti-infection field in China. Through AMS accurate treatment program, "accompany us to curb drug resistance" interviews with prominent experts, and high-quality conferences like Meiyu Summit multidisciplinary forum, we create a top academic platform and spread the strongest voice on rational antibiotic use under the direction of anti-infection leaders.

Meiyu Summit Multidisciplinary Forum
Meiyu Summit Multidisciplinary Forum
Meiyu Summit Multidisciplinary Forum

The Meiyu Summit multidisciplinary forum has been successfully held for five sessions since 2017 and has become an influential and high-profile anti-infection meeting in the field. A total of more than 300 well-known experts from various disciplines are invited, with topics incorporating the fields of infection control, severe illness, pediatrics, emergency medicine, respiratory medicine, geriatrics, neurosurgery, hematology, and microbiology. The Forum was held in more than 20 cities in China, including Beijing, Shanghai, Suzhou, and Guangzhou. The participants shared their multidisciplinary clinical treatment experiences and led the new concept of anti-infection treatment.

Host-Infection-Antibiotics Summit
Host-Infection-Antibiotics Summit
Host-Infection-Antibiotics Summit

The Host-Infection-Antibiotics Summit was initiated and named by academician Zhong Nanshan, a recipient of the Medal of the Republic, and has been successfully held for three sessions. Over the past three years, more than 100 top anti-infection experts have been gathered to discuss the hot topics on curbing drug resistance, antibiotic management, and treatment of severe infectious cases, promote the communication of multidisciplinary infection diagnosis and treatment, improve the level of antimi

AMS accurate treatment
AMS accurate treatment
AMS accurate treatment

The AMS program helps 200+ core hospitals to provide accurate treatment and continues to promote the rational use of antibiotics.

"Accompany us to curb drug resistance" interviews with prominent experts
"Accompany us to curb drug resistance" interviews with prominent experts

"Accompany us to curb drug resistance" interviews with prominent experts promote the containment of drug resistance and the rational use of antibiotics.

Copyright @2016 住友制药. All rights reserved  (沪)  -非经营性-2016-0021  沪ICP备16016494号-3   沪公网安备 31010102002939号
You are leaving the official website of
Sumitomo Pharma (Suzhou) Co., Ltd.

You are about to leave the official website of Sumitomo Pharma (Suzhou) Co., Ltd. and be redirected to a third-party website. Please be aware of the risks involved.